Investigating the biomechanics of femoroacetabular impingement and its effects
An Integrated Biomechanical Investigation of Subjects With Symptomatic FAI and Two Groups of Asymptomatic Controls: a Comparison in Dynamic Tasks
This study tests how the way your hip moves affects pain and symptoms in people with femoroacetabular impingement to help improve diagnosis and treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 99 (estimated) |
| Ages | 21 Years to 35 Years |
| Sex | Male |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Locations | 1 site (Leuven, Vlaams-Brabant) |
| Trial ID | NCT06272292 on ClinicalTrials.gov |
What this trial studies
This project examines femoroacetabular impingement (FAI), a condition caused by anatomical abnormalities in the hip joint that can lead to pain and restricted movement. The study aims to differentiate between symptomatic and asymptomatic patients by analyzing the biomechanical factors influencing hip motion and symptom presentation. Participants will undergo EOS imaging and 3D motion lab analysis to gather comprehensive data on their hip mechanics. The goal is to improve the understanding of FAI and potentially enhance diagnosis and treatment strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are males aged 21 to 35 with symptomatic or asymptomatic CAM-type femoroacetabular impingement.
Not a fit: Patients with pincer FAI morphology or radiological signs of osteoarthritis will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better diagnostic methods and treatment options for patients suffering from femoroacetabular impingement.
How similar studies have performed: While there have been studies on femoroacetabular impingement, this approach focusing on biomechanical analysis in both symptomatic and asymptomatic patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Exclusion Criteria: \- Participants in all three study groups will be excluded if x-ray scans shows a pincer FAI morphology or radiological sign of osteoarthritis. Inclusion Criteria: * All participants will be males aged between 21 and 35 years old. * For symptomatic CAM-FAI patients 1. The presence of CAM-FAI morphology at the head-neck junction of the femur 2. Alpha angle \>60 3. Reduced hip internal rotation (IR\<15) * For asymptomatic CAM controls: 1\. Exhibit asymptomatic CAM on x-ray scansAlpha angle \>60 * For Healthy control group: 1. Exhibit no symptoms or abnormal morphologies of the proximal femur (Alpha angle \>60 , IR\>15).
Where this trial is running
Leuven, Vlaams-Brabant
- University Hospitals of Leuven — Leuven, Vlaams-Brabant, Belgium (Recruiting)
Study contacts
- Principal investigator: Stijn Ghijselings, MD — Universitaire Ziekenhuizen KU Leuven
- Study coordinator: Stijn Ghijselings, MD
- Email: stijn.ghijselings@uzleuven.be
- Phone: +32 16 33 88 18
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.